Substitution treatment for problem drug users is now widespread in the European Union (EU). Trials, mostly with methadone, started in the late-1960s, mainly in northern Europe. By the mid-1990s, substitution had been implemented in all EU Member States. A substantial European consensus now exists on the benefits of such treatment. However, in some countries, it remains a sensitive topic.